Prevalence and Determinants of Dengue Virus Immunoglobulin among Febrile Patients Attending Naval Medical Centre Victoria Island, Lagos State

Background: Dengue fever, (df) is a mosquito-borne disease caused by the dengue virus. Infection with dengue virus is a major cause of morbidity in the tropical and sub-tropical parts of the world. In about 60% of cases, it gives rise to undifferentiated fever which is clinically indistinguishable f...

Full description

Bibliographic Details
Published in:Global Biosecurity
Main Authors: Mohammed, Ahmadu Shehu, Odegbemi, Odekunle Bola, Igwe, Chinedu, Hussain, Nurudeen AA, Abaye, Biobelu, Adekanye, Usman Oladipo
Format: Article in Journal/Newspaper
Language:English
Published: University of New South Wales 2021
Subjects:
Online Access:https://account.jglobalbiosecurity.com/index.php/up-j-gb/article/view/110
https://doi.org/10.31646/gbio.110
id ftjgbiosecurity:oai:ojs.pkp.sfu.ca:article/110
record_format openpolar
spelling ftjgbiosecurity:oai:ojs.pkp.sfu.ca:article/110 2023-06-11T04:17:29+02:00 Prevalence and Determinants of Dengue Virus Immunoglobulin among Febrile Patients Attending Naval Medical Centre Victoria Island, Lagos State Mohammed, Ahmadu Shehu Odegbemi, Odekunle Bola Igwe, Chinedu Hussain, Nurudeen AA Abaye, Biobelu Adekanye, Usman Oladipo 2021-10-05 application/pdf text/html https://account.jglobalbiosecurity.com/index.php/up-j-gb/article/view/110 https://doi.org/10.31646/gbio.110 eng eng University of New South Wales https://account.jglobalbiosecurity.com/index.php/up-j-gb/article/view/110/321 https://account.jglobalbiosecurity.com/index.php/up-j-gb/article/view/110/322 https://account.jglobalbiosecurity.com/index.php/up-j-gb/article/view/110 doi:10.31646/gbio.110 Copyright (c) 2021 The Author(s) https://creativecommons.org/licenses/by/4.0 Global Biosecurity; Vol. 3 (2021) 2652-0036 Dengue fever Febrile Military Immunoglobulins info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 2021 ftjgbiosecurity https://doi.org/10.31646/gbio.110 2023-05-05T15:10:08Z Background: Dengue fever, (df) is a mosquito-borne disease caused by the dengue virus. Infection with dengue virus is a major cause of morbidity in the tropical and sub-tropical parts of the world. In about 60% of cases, it gives rise to undifferentiated fever which is clinically indistinguishable from other viral infections. Dengue fever is known to occur in Nigeria, but the magnitude of this disease remains unclear. This study was done to determine the prevalence and determinants of df immunoglobulins (Ig) among patients attending a military hospital in Lagos.Methods: Systematic random sampling was used to recruit participants. Study participants were patients presenting with febrile illness at Naval Medical Centre, Victoria Island, Lagos. A semi-structured, interviewer-administered questionnaire was used to collect data and 3 millilitres venous blood was drawn from each participant. Anti-dengue IgM and IgG was determined from whole blood using lateral flow chromatographic immunoassay in line with manufacturer’s instructions. Thick blood film was used for malaria microscopy. Epi-info version 7.2 was employed for data analysis using descriptive statistics and bivariate analysis at 5% level of significance.Results: Mean age of study participants was 30.1 ± 13.6 years and 182 (59.9%) were males. The prevalence of df IgM and IgG was 8.5% and 18.0% respectively. Malaria-dengue fever co-infection was 10.8%. Individuals with malaria were twice less likely to have df (OR: 0.46, 95%CI: 0.27 - 0.78). Military personnel and their relations were about 3 times less likely to have df (OR: 0.35, 95%CI: 0.18 - 0.66). Joint pain was significantly associated with df (OR: 1.78, 95%CI: 1.05 - 2.99).Conclusions: A significant proportion of study population had both df IgM and IgG. Screening for df should be part of routine tests amongst patients that presents with febrile illness particularly those with joint pain. Article in Journal/Newspaper Victoria Island Global Biosecurity (E-Journal) Global Biosecurity 3
institution Open Polar
collection Global Biosecurity (E-Journal)
op_collection_id ftjgbiosecurity
language English
topic Dengue fever
Febrile
Military
Immunoglobulins
spellingShingle Dengue fever
Febrile
Military
Immunoglobulins
Mohammed, Ahmadu Shehu
Odegbemi, Odekunle Bola
Igwe, Chinedu
Hussain, Nurudeen AA
Abaye, Biobelu
Adekanye, Usman Oladipo
Prevalence and Determinants of Dengue Virus Immunoglobulin among Febrile Patients Attending Naval Medical Centre Victoria Island, Lagos State
topic_facet Dengue fever
Febrile
Military
Immunoglobulins
description Background: Dengue fever, (df) is a mosquito-borne disease caused by the dengue virus. Infection with dengue virus is a major cause of morbidity in the tropical and sub-tropical parts of the world. In about 60% of cases, it gives rise to undifferentiated fever which is clinically indistinguishable from other viral infections. Dengue fever is known to occur in Nigeria, but the magnitude of this disease remains unclear. This study was done to determine the prevalence and determinants of df immunoglobulins (Ig) among patients attending a military hospital in Lagos.Methods: Systematic random sampling was used to recruit participants. Study participants were patients presenting with febrile illness at Naval Medical Centre, Victoria Island, Lagos. A semi-structured, interviewer-administered questionnaire was used to collect data and 3 millilitres venous blood was drawn from each participant. Anti-dengue IgM and IgG was determined from whole blood using lateral flow chromatographic immunoassay in line with manufacturer’s instructions. Thick blood film was used for malaria microscopy. Epi-info version 7.2 was employed for data analysis using descriptive statistics and bivariate analysis at 5% level of significance.Results: Mean age of study participants was 30.1 ± 13.6 years and 182 (59.9%) were males. The prevalence of df IgM and IgG was 8.5% and 18.0% respectively. Malaria-dengue fever co-infection was 10.8%. Individuals with malaria were twice less likely to have df (OR: 0.46, 95%CI: 0.27 - 0.78). Military personnel and their relations were about 3 times less likely to have df (OR: 0.35, 95%CI: 0.18 - 0.66). Joint pain was significantly associated with df (OR: 1.78, 95%CI: 1.05 - 2.99).Conclusions: A significant proportion of study population had both df IgM and IgG. Screening for df should be part of routine tests amongst patients that presents with febrile illness particularly those with joint pain.
format Article in Journal/Newspaper
author Mohammed, Ahmadu Shehu
Odegbemi, Odekunle Bola
Igwe, Chinedu
Hussain, Nurudeen AA
Abaye, Biobelu
Adekanye, Usman Oladipo
author_facet Mohammed, Ahmadu Shehu
Odegbemi, Odekunle Bola
Igwe, Chinedu
Hussain, Nurudeen AA
Abaye, Biobelu
Adekanye, Usman Oladipo
author_sort Mohammed, Ahmadu Shehu
title Prevalence and Determinants of Dengue Virus Immunoglobulin among Febrile Patients Attending Naval Medical Centre Victoria Island, Lagos State
title_short Prevalence and Determinants of Dengue Virus Immunoglobulin among Febrile Patients Attending Naval Medical Centre Victoria Island, Lagos State
title_full Prevalence and Determinants of Dengue Virus Immunoglobulin among Febrile Patients Attending Naval Medical Centre Victoria Island, Lagos State
title_fullStr Prevalence and Determinants of Dengue Virus Immunoglobulin among Febrile Patients Attending Naval Medical Centre Victoria Island, Lagos State
title_full_unstemmed Prevalence and Determinants of Dengue Virus Immunoglobulin among Febrile Patients Attending Naval Medical Centre Victoria Island, Lagos State
title_sort prevalence and determinants of dengue virus immunoglobulin among febrile patients attending naval medical centre victoria island, lagos state
publisher University of New South Wales
publishDate 2021
url https://account.jglobalbiosecurity.com/index.php/up-j-gb/article/view/110
https://doi.org/10.31646/gbio.110
genre Victoria Island
genre_facet Victoria Island
op_source Global Biosecurity; Vol. 3 (2021)
2652-0036
op_relation https://account.jglobalbiosecurity.com/index.php/up-j-gb/article/view/110/321
https://account.jglobalbiosecurity.com/index.php/up-j-gb/article/view/110/322
https://account.jglobalbiosecurity.com/index.php/up-j-gb/article/view/110
doi:10.31646/gbio.110
op_rights Copyright (c) 2021 The Author(s)
https://creativecommons.org/licenses/by/4.0
op_doi https://doi.org/10.31646/gbio.110
container_title Global Biosecurity
container_volume 3
_version_ 1768376725928935424